Insights

Get in Touch

Our Locations

Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment

Related Services & Solutions

Related Thought Leaders Insights

Video

Sense and Sensitivity – or the Pursuit of Actionable Insight in the Age of Single-Cell Biology

Speaker - Oswaldo A Lozoya, PhD, Genomics Staff Scientist - TSAIL, Q² Solutions As part of the Machine Learning and Single Cell Genomics in Public Health session, Oswaldo presents insights,...

Insight Brief

Risk Management for Biotech Companies in Clinical Trials

When we discuss risk, it’s often focused on the negative threats where there is a need to mitigate or avoid threats to the project that could impact timelines, deliverables or quality. One can look...

Insight Brief

Preparation for Biotech Testing or Clinical Trials

Your clinical trial may involve samples from multiple sites to be tested by multiple laboratories. The data that flows from those tests may travel to multiple end users as well. Proper planning of...